Brain cancer trial tests implanted wafers plus immunotherapy

NCT ID NCT05083754

Recruiting now Disease control Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety and effectiveness of a multi-part treatment for adults newly diagnosed with glioblastoma, an aggressive brain cancer. The treatment combines chemotherapy wafers implanted during surgery, a new immunotherapy drug, standard radiation, and a common chemotherapy pill. The main goal is to see if this combination is safe and tolerable, while also measuring how long patients live without their cancer getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Johns Hopkins Medical Institution
RECRUITING

Baltimore, Maryland, 21287, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

GLIOBLASTOMA MULTIFORME